← Brian P. Skorney

What podcasts say about Brian P. Skorney

Every statement, with the speaker, the exact quote and the moment it was said.

What Brian P. Skorney has said on podcasts

8 statements · 5 positive · 3 negative

  1. on Biotech degrossingNegativeOct 16, 2026· Biotech Hangout

    Biotech degrossing can create a cycle of worsening fund performance.

    “it becomes a cycle of sort of everyone seeing performance kind of get hit from, you know, the start of a degrossing.”

    Listen at 8:03

    Open the episode · Episode 199 - October 16, 2026
  2. on Hedge-fund degrossingNegativeOct 16, 2026· Biotech Hangout

    Hedge-fund degrossing pressure began in early summer.

    “that pressure's kind of been on since early summer.”

    Listen at 9:58

    Open the episode · Episode 199 - October 16, 2026
  3. on BiotechnologyPositiveOct 16, 2026· Biotech Hangout

    Biotech is far from being in a bubble.

    “I think we're very far from a bubble.”

    Listen at 17:11

    Open the episode · Episode 199 - October 16, 2026
  4. on IPF clinical trialsNegativeOct 16, 2026· Biotech Hangout

    IPF clinical trials have been difficult.

    “clinical trials here have been like... Really tough.”

    Listen at 33:07

    Open the episode · Episode 199 - October 16, 2026
  5. on Combination IPF therapiesPositiveOct 16, 2026· Biotech Hangout

    Combining tolerable IPF mechanisms could substantially advance treatment.

    “that would be a great advance if you could kind of stack additional tolerable mechanisms”

    Listen at 36:32

    Open the episode · Episode 199 - October 16, 2026
  6. on LivmarliPositiveOct 16, 2026· Biotech Hangout

    Livmarli produced consistent placebo-adjusted reductions in pruritus.

    “it showed pretty, you know, what I would say is very consistent. placebo-adjusted reductions, reductions from base, you know, good magnitude of reduction in pruritus from baseline.”

    Listen at 38:02

    Open the episode · Episode 199 - October 16, 2026
  7. on Livmarli biliary atresia indicationPositiveOct 16, 2026· Biotech Hangout

    Mirum plans to seek an indication potentially adding 2,000 US and EU biliary-atresia patients.

    “they're going to file for this indication, which could potentially add another 2,000 US and EU patients just in the biliary atresia side of things.”

    Listen at 38:14

    Open the episode · Episode 199 - October 16, 2026
  8. on IBAT inhibitorsPositiveOct 16, 2026· Biotech Hangout

    IBAT inhibitors dramatically reduce cholestasis-related pruritus.

    “if a person has pruritus due to cholestasis, giving them an IBAT inhibitor will really dramatically reduce that pruritus.”

    Listen at 38:52

    Open the episode · Episode 199 - October 16, 2026

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.